Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the 'Docetaxel Era': Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

Taneja Samir S.

首页> 外文期刊>The Journal of Urology >Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the 'Docetaxel Era': Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

【24h】

Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the 'Docetaxel Era': Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

机译：RE：在“多西紫杉醇时代”中的新诊断转移前列腺癌中生存：来自917例踩踏试验控制臂的数据（MRC PR08，CRUK / 06/019）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2016年第2期|共1页
作者
Taneja Samir S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) [J] . Taneja Samir S. The Journal of Urology . 2016,第2期

机译：RE：在“多西紫杉醇时代”中的新诊断转移前列腺癌中生存：来自917例踩踏试验控制臂的数据（MRC PR08，CRUK / 06/019）
2. Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era'': Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) [J] . James Nicholas David, Spears Melissa R., Clarke Noel W., European urology . 2015,第6期

机译：在“多西他赛时代”中新诊断为转移性前列腺癌的患者的生存：来自STAMPEDE试验对照组的917例患者的数据（MRC PR08，CRUK / 06/019）
3. Survival with newly diagnosed metastatic prostate cancer in the docetaxel era: Data from 917 patients in the control arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) [J] . Nicholas David James, Noel W. Clarke, Joanna Gale, Indian heart journal . 2015,第6期

机译：在Docetaxel时代的新诊断转移前列腺癌中生存：来自917例踩踏试验控制臂的数据（MRC PR08，CRUK / 06/019）
4. Irrefutable evidence for the use of docetaxel in newly diagnosed metastatic prostate cancer: results from the STAMPEDE and CHAARTED trials [O] . Robert J. van Soest, Ronald de Wit 2015

机译：在新诊断的转移性前列腺癌中使用多西他赛的无可辩驳的证据：STAMPEDE和CHAARTED试验的结果
5. Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) [O] . James, Nicholas David, Spears, Melissa R, Clarke, Noel W, 2015

机译：在“多西他赛时代”中新诊断为转移性前列腺癌的患者的生存：来自STAMPEDE试验对照组的917例患者的数据（MRC PR08，CRUK / 06/019）

Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the 'Docetaxel Era': Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

著录项

相似文献

相关主题

期刊订阅